Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC labeling meeting postponed

This article was originally published in The Rose Sheet

Executive Summary

FDA/industry working group meeting scheduled for Nov. 1 postponed due to late submission of supporting docuemtns. Due to other commitments, FDA "personnel will not permit a shortened review time of the materials," the agency said. The first available date to reschedule the OTC labeling meeting is Nov. 23 from 10 a.m. to 12 p.m. Once FDA receives the supporting materials, it will outline an agenda
Advertisement

Related Content

OTC Label Trade Dress, Multiple Columns Need Quick Resolution - CHPA
OTC Labeling Final Rule Two-Year Extension Requested By CTFA
OTC Label Trade Dress, Multiple Columns Need Quick Resolution - CHPA
OTC Labeling Final Rule Two-Year Extension Requested By CTFA
Advertisement
UsernamePublicRestriction

Register

RS007297

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel